dc.contributor.authorLi, Liang
dc.contributor.authorChow, Vincent T.K.
dc.contributor.authorTan, Nguan Soon
dc.date.accessioned2016-07-15T05:31:45Z
dc.date.available2016-07-15T05:31:45Z
dc.date.issued2015
dc.identifier.citationLi, L., Chow, V. T. K., & Tan, N. S. (2015). Targeting vascular leakage in lung inflammation. Oncotarget, 6(23), 19338-19339.en_US
dc.identifier.urihttp://hdl.handle.net/10220/40942
dc.description.abstractThe 2009 outbreak of H1N1 caught many off guard-not least those responsible for tracking the emergence of new influenza strains and outbreaks [1]. Although the influenza A H1N1 pandemic in 2009 proved relatively mild, it still claimed over 14,000 lives across the globe. Given the relentless and rapid mutation of influenza viruses, predicting the onset of pandemics is virtually impossible. Moreover, the development of effective vaccines and antiviral agents against this renegade RNA virus also lags behind the emergence of new influenza strains. Hence, there is considerable interest in strategies that target host responses to combat influenza infection and pneumonia to counter the occurrence of antiviral-resistant strains.en_US
dc.format.extent2 p.en_US
dc.language.isoenen_US
dc.relation.ispartofseriesOncotargeten_US
dc.rights© 2015 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.subjectVascular leakageen_US
dc.subjectLung inflammationen_US
dc.titleTargeting vascular leakage in lung inflammationen_US
dc.typeJournal Article
dc.contributor.schoolSchool of Biological Sciencesen_US
dc.identifier.doihttp://dx.doi.org/10.18632/oncotarget.4907
dc.description.versionPublished versionen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record